Vulvar recurrences after intensity-modulated radiation therapy for squamous cell carcinoma of the anus
American Journal of Clinical Oncology Apr 28, 2018
Bagshaw HP, et al. - In this retrospective review, researchers examined the impact of definitive chemotherapy and intensity-modulated radiation therapy (IMRT) on localregional control (LRC), distant metastasis free survival, disease-free survival, overall survival (OS), and toxicity in patients treated for squamous cell carcinoma of the anus at their institution since 2005. Using the Kaplan-Meier curves, LRC and OS were assessed. The overall cohort showed limited recurrence rates. Two vulvar recurrences were identified within the avoided external genitalia in patients treated with IMRT-based chemoradiation. The risk for subclinical involvement of in-transit vulvar dermal lymphatics and subsequent recurrence may exist for patients with a locally advanced primary tumor and bulky bilateral inguinal or pelvic disease. If proved by a similar pattern of recurrence at other institutions, the external genitalia may need to be reclassified from an avoidance structure to a clinical treatment volume in patients with locally advanced anal cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries